Recent activity at Minnesota Department of Human Services
Meetings, budgets, and plans from this organization.
Nov 13, 2026·Board meeting agenda
Seniors and People With Disabilities on Managed Care Advisory Committee Advisory Committee Meeting
The committee meeting covered several key topics, including health plan updates for 2026, specifically regarding the reinstatement of Medicare Part D co-pays for MSHO and Integrated SNBC programs. Presentations were held regarding the SNBC Accessibility Survey and the Medical Assistance Estate Recovery process. Additionally, the committee discussed the redesign of the Health Risk Assessment (HRA) tool, reviewing feedback on engagement, and evaluating potential new survey questions related to psychosocial health and activities of daily living. The committee also provided an opportunity for member questions and public comment.
Enterprise
Get verified public-sector contacts at scale
Find verified emails, direct dials, role context, job-change updates, and organization signals across every public-sector account you sell to.
The committee meeting agenda includes a public forum, a report from the Chair, DHS housekeeping, and discussions on old and new business. Key topics for discussion involve specialty drugs for continued prior authorization, specifically Lyfgenia, Kygevvi, Loargys, Yuviwel, Avlayah, Baxfendy, and Hepcludex. Additionally, the agenda covers a Preferred Drug List (PDL) review for various therapeutic classes such as angiotensin modulators, antifungals, COPD agents, growth hormones, and HAE treatments, along with a consent agenda featuring various antiviral and antibiotic agents.
Oct 21, 2026·Board meeting
Drug Formulary Committee Meeting Minutes
The committee discussed and recommended prior authorization criteria for several specialty drugs, including Lyfgenia, Kygevvi, Loargys, Yuviwel, Avlayah, Baxfendy, and Hepcludex. They also conducted a Preferred Drug List (PDL) review across multiple therapeutic classes, determining the status of various medications such as Angiotensin Modulator Combinations, Antiemetic/Antivertigo Agents, Antifungals, Calcium Channel Blockers, COPD Agents, Growth Hormone, HAE Treatments, Ophthalmic Antibiotics, and Opiate Dependence Treatments. Additionally, the committee addressed departmental housekeeping regarding pharmacy acquisition cost surveys and approved several consent agenda items.
Oct 21, 2026·Board meeting
Minnesota Long-Term Services And Supports Advisory Council Advisory Council Meeting
The Advisory Council discussed scheduling a special virtual meeting in November for the purpose of voting on the final legislative report. Key discussions focused on potential meeting dates, equity concerns regarding accessibility and member participation for those with lived experience, and an exploration of open meeting law requirements concerning quorum and voting procedures. The council also addressed housekeeping items, including public comment guidelines and meeting protocols.